指南与共识心力衰竭与心肌病心律失常

心房颤动对心力衰竭指南导向治疗的影响:JACC最新综述

Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
指南 / 共识 · J Am Coll Cardiol · 2024-01-01

心房颤动(AF)与心力衰竭(HF)常共存,超过半数HF患者合并AF。本文综述了HF指南导向药物治疗(GDMT)对AF预防的影响,以及GDMT在合并与不合并AF患者中的获益差异。

要点

  • 超过半数HF患者合并AF,AF与症状负担加重、住院更频繁及预后更差相关。
  • HF的GDMT可影响AF的发生率。
  • AF一旦出现,可能影响部分GDMT组分的疗效。

核心结论

  • AF与HF常共存且相互影响,GDMT对AF的预防作用及其在合并AF患者中的获益需被认识。

研究设计与样本

  • 本文为JACC状态综述,讨论GDMT在不同射血分数谱中对AF预防的作用及在合并与不合并AF患者中的获益。

主要发现

  • 超过半数HF患者合并AF,两者均与显著发病率和死亡率相关。
  • HF患者诊断AF与症状负担加重、住院更频繁及预后更差相关。
  • HF的GDMT可影响AF发生率,AF一旦出现可影响部分GDMT组分的疗效。

临床怎么用

  • 对HF患者应关注AF的筛查与管理,并认识AF对GDMT疗效的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF) and heart failure (HF) are common cardiovascular conditions that frequently coexist. Among patients with HF, more than one-half also have AF. Both are associated with significant morbidity and mortality. Moreover, the prevalence of each is increasing globally, and this trend is expected to continue owing to an aging population and increased life expectancy. Diagnosis of AF in a patient with HF is associated with greater symptom burden, more frequent hospitalizations, and a worse prognosis. Guideline-directed medical therapy (GDMT) for HF can affect the incidence of AF. Once present, AF can influence the efficacy of some components of GDMT for HF. In this review, we discuss the effect of GDMT for HF across the spectrum of ejection fraction on prevention of AF as well as the benefit of GDMT in patients with vs without AF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Newman, O'Meara, Böhm, et al. Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024. PMID: 38418008. doi:10.1016/j.jacc.2023.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。